Jeena Sikho Lifecare Employee Stock Options
Jeena Sikho Lifecare received BSE in-principle approval to list up to 6,50,000 ESOS 2024 shares. Both NSE and BSE approvals are now in place.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
53 announcements with these filters
Jeena Sikho Lifecare received BSE in-principle approval to list up to 6,50,000 ESOS 2024 shares. Both NSE and BSE approvals are now in place.
Jeena Sikho Lifecare has launched two new Ayurvedic products, Acharya Ji's Amrit Tattava Vati and Acharya Ji's Oja Amrit Vati, in the domestic market.
Jeena Sikho Lifecare postponed its new Lucknow hospital's commercial operations to December 2026 from August. The delay stems from expanded work scope and adverse site weather.
Jeena Sikho Lifecare Limited received NABH accreditation for its Pune hospital, affirming its adherence to quality healthcare standards and operational excellence.
Jeena Sikho Lifecare launched two new Ayurvedic products, Jeevanodya Vati and Ojavardhan Vati. This expands the company's portfolio of healthcare and wellness offerings.
Jeena Sikho Lifecare Limited informed shareholders about the web-link to access its 2025-26 Annual Report and 9th AGM Notice.
Jeena Sikho Lifecare Limited will hold its 9th Annual General Meeting on September 28, 2026. The notice covers director appointments, reappointments, and a final dividend declaration.
Jeena Sikho Lifecare has fixed September 21, 2026, as the record date for the final dividend of Rs. 4.5 per share for the financial year 2025-26. The Annual General Meeting is scheduled for September 28, 2026.
Jeena Sikho Lifecare approved its Annual Report, fixed the AGM date for September 28, 2026, and set the dividend record date for September 21, 2026.
Jeena Sikho Lifecare Limited launched nine new Ayurvedic and healthcare products, including Headache Relief Patches and various herbal Arishtas. The expansion targets the domestic wellness market.
Jeena Sikho Lifecare released an update on Q1 FY27 operational performance, highlighting segment-wise revenue growth and a strategic shift towards higher-quality private-pay inpatient services.
Jeena Sikho Lifecare announced the publication of six Ayurvedic research case studies in an international multidisciplinary journal. This highlights the company's ongoing commitment to clinical research.
Jeena Sikho Lifecare announced the publication of seven medical case studies authored by its professionals in Ayurvedic research journals. This reflects its commitment to clinical practice.
Jeena Sikho Lifecare Limited is establishing a new Ayurvedic hospital in Bareilly, Uttar Pradesh, with an investment of ₹0.85 Crore, operational by November 2026.
Jeena Sikho is aggressively pivoting from low-margin government business to a high-margin cash-and-carry wellness ecosystem. Management is prioritizing operating leverage and 'prevention-first' health models to drive 30% annual growth.
JSLL reported Q1FY27 revenue of Rs 224.4 Cr (+29% YoY) with an EBITDA margin of 41%. The company is expanding its integrated Ayurveda model across 2,400 operational beds.
Jeena Sikho Lifecare Limited has announced the re-appointment of three directors, including the Managing Director, for a five-year term effective August 25, 2026.
Jeena Sikho Lifecare Ltd reported revenue from operations of ₹224.4 Cr (+28.7% YoY) and net profit of ₹65.9 Cr (+28.5% YoY) for Q1 FY27.
Jeena Sikho Lifecare Limited executed a Room Block & Services Licence Agreement to establish an integrated Wellness Centre at Ajna Resorts, Manali, Himachal Pradesh.
Jeena Sikho Lifecare Limited has launched 'Amrit Dhara Drops 20 ml' to expand its Ayurvedic product portfolio for the domestic market.
Jeena Sikho Lifecare will open a new Wellness Centre at Ajna Resorts, Manali, under a ₹7.66 Crore licence agreement. The expansion adds 30 luxury guest rooms.
Jeena Sikho Lifecare Limited has scheduled a board meeting on August 07, 2026. The board will consider and approve unaudited financial results for the quarter ended June 2026.
Jeena Sikho Lifecare Limited has launched a new range of Ayurvedic pain relief patches to expand its existing healthcare and wellness product portfolio.
Jeena Sikho Lifecare Limited is establishing a new Client Support Centre in Noida, Uttar Pradesh. The expansion, costing ₹2.37 Crore, aims to strengthen customer service and operational infrastructure.
Jeena Sikho Lifecare will establish a new 60-bed Ayurvedic hospital in Kalyani, West Bengal, by October 2026. This expansion involves a capital investment of ₹1.30 Crore.
Jeena Sikho Lifecare Ltd has filed its quarterly shareholding pattern disclosure as per SEBI regulations. This routine filing provides details of the company's equity distribution.
Jeena Sikho Lifecare announced the publication of two Ayurvedic case studies in the International Journal of Advanced Research. The studies focus on kidney disease management.
Jeena Sikho Lifecare appointed Priya Goyal as Company Secretary following Smita Chaturvedi's resignation. Four new directors were also appointed to the Board.
Jeena Sikho Lifecare received GST Appreciation Certificates from the Ministry of Finance for FY 2025-26. The recognition covers operations in Maharashtra, Uttar Pradesh, and Haryana.
Jeena Sikho Lifecare signed a five-year agreement to establish a new Research Institute and Knowledge Centre in Chandigarh. The facility expansion involves no rental costs.